Literature DB >> 10815621

Basal secretion of lysozyme from human airways in vitro.

P Roger1, J P Gascard, V T de Montpreville, C Brink.   

Abstract

The aim of this study was to examine the basal release of lysozyme from isolated human lung tissues. Measurements of lysozyme in the fluids derived from lung preparations were performed using a rate-of-lysis assay subsequent to acidification of the biological samples. Lysozyme released from bronchial preparations into fluids was greater than that observed for parenchymal tissues. The lysozyme quantities detected in bronchial fluids were not modified by removal of the surface epithelium. Furthermore, the quantities of lysozyme in bronchial fluids was correlated with the size of the bronchial preparations. These results suggest that the lysozyme was principally secreted by the human bronchi (submucosal layer) rather than by parenchyma tissues and that a greater release was observed in the proximal airways.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10815621      PMCID: PMC1781815          DOI: 10.1080/09629359990333

Source DB:  PubMed          Journal:  Mediators Inflamm        ISSN: 0962-9351            Impact factor:   4.711


  12 in total

1.  PURIFICATION AND ANALYSIS OF HUMAN SALIVA LYSOZYME.

Authors:  J F PETIT; P JOLLES
Journal:  Nature       Date:  1963-10-12       Impact factor: 49.962

2.  Ultrastructural immunocytochemical localisation of lysozyme in human bronchial glands.

Authors:  D Bowes; B Corrin
Journal:  Thorax       Date:  1977-04       Impact factor: 9.139

3.  Tissue distribution of lysozyme in man.

Authors:  M Klockars; S Reitamo
Journal:  J Histochem Cytochem       Date:  1975-12       Impact factor: 2.479

4.  A simple and ultrasensitive enzymatic assay for the quantitative determination of lysozyme in the picogram range.

Authors:  M E Selsted; R J Martinez
Journal:  Anal Biochem       Date:  1980-11-15       Impact factor: 3.365

5.  Lower respiratory tract lactoferrin and lysozyme arise primarily in the airways and are elevated in association with chronic bronchitis.

Authors:  A B Thompson; T Bohling; F Payvandi; S I Rennard
Journal:  J Lab Clin Med       Date:  1990-02

6.  Lysozyme and lactoferrin in sputum from patients with chronic obstructive lung disease.

Authors:  O Harbitz; A O Jenssen; O Smidsrød
Journal:  Eur J Respir Dis       Date:  1984-10

7.  Soluble proteins of bronchopulmonary secretions from patients with cystic fibrosis, asthma, and bronchitis.

Authors:  T D Brogan; H C Ryley; L Neale; J Yassa
Journal:  Thorax       Date:  1975-02       Impact factor: 9.139

8.  The effects of peptide histidine isoleucine and neuropeptide Y on mucus volume output from the ferret trachea.

Authors:  S E Webber
Journal:  Br J Pharmacol       Date:  1988-09       Impact factor: 8.739

9.  Pathophysiology of rhinitis. Lactoferrin and lysozyme in nasal secretions.

Authors:  G D Raphael; E V Jeney; J N Baraniuk; I Kim; S D Meredith; M A Kaliner
Journal:  J Clin Invest       Date:  1989-11       Impact factor: 14.808

10.  An interaction between lysozyme and mucus glycoproteins. Implications for density-gradient separations.

Authors:  J M Creeth; J L Bridge; J R Horton
Journal:  Biochem J       Date:  1979-09-01       Impact factor: 3.857

View more
  2 in total

1.  ATP induced MUC5AC release from human airways in vitro.

Authors:  P Roger; J P Gascard; J Bara; V T de Montpreville; M Yeadon; C Brink
Journal:  Mediators Inflamm       Date:  2000       Impact factor: 4.711

2.  The oral cavity and age: a site of chronic inflammation?

Authors:  Magnus Bäck; Hanna Hlawaty; Carlos Labat; Jean-Baptiste Michel; Charles Brink
Journal:  PLoS One       Date:  2007-12-26       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.